Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds https://t.co/bbNYJzBuE1 via @statnews
Nice article by Mario Aguilar showing the benefit of reSET and reSET-O to patients in need at MassHealth. Hopefully this will move legislators
Sorry, the government’s not paying for your therapy app https://t.co/zcLOSwOWfN via @politico
Action is needed for these critical prescription digital therapeutics to become reimbursed. Good luck to everyone moving this legislation forward
We are proud Krista Gullickson is one of our clinical coaches. She recently advocated for legislation to increase access to cardiopulmonary rehab services, an essential treatment to help those with COPD recover from complications.
#COPD#virtualcare#patientaccess
Today is National Lung Health Day, a time to recognize all the essential bodily functions your lungs support. This organ is vital in supporting our health and wellness. Learn more about how we support our patient's lung health goals here: https://t.co/FwxpUO2gAP
Last month we announced the interim results of ASPIRE. The trial has now closed and our teams are hard at work analyzing the full results. Learn more and sign up to be the first to receive them here: https://t.co/IUmmz5k3WH
#COPD#BreatheFreely#LiveFully#Wellinks
On October 5, our Chief Medical Officer Dr. Abi Sundaramoorthy will be joining a panel at the @BeckersHR Health IT + Digital Health + RCM Annual Meeting to discuss her experience at the intersection of VC and health tech.
To register, visit: https://t.co/ZhWSIkJbVB
Nice to see the Commissioner calling for solutions for chronic diseases. We at @WellinksHealth have developed a virtual-first solution for the care and management of COPD that meets patients where they are and allows them to live fully and breathe freely
https://t.co/nzbjbUF4yU
I’m excited to announce @Wellinks’ latest clinical study in partnership with @HartfordHealthC. Together, we’re working to reduce hospital readmissions and close gaps in care for people with COPD. https://t.co/2o5Jcq0utM
As @WellinksHealth continues to refine our product offering, we are always striving to deliver more evidence-based programming to our members. This is why we are excited to announce @SparoHealth is now part of Wellinks. https://t.co/lKhimzm7Ps
I am thrilled to welcome Dr. Abi Sundaramoorthy to the @WellinksHealth team! Dr. Sundaramoorthy has a proven track record of leading successful clinical programs and fostering deep connections to put the patient first. https://t.co/K9UtVx2iK9
At @WellinksHealth, we know that the most important first step to building a successful virtual care model for COPD is developing a strong, clinical evidence base.
I wrote about our team’s commitment to clinical rigor: https://t.co/0nOTWZ8yCT
Today, we announced that CMS has granted a new HCPCS code for Prescription Digital Behavioral Therapy including prescription digital therapeutics (PDTs) such as Pear’s commercial products. Read more here: https://t.co/BNFnbzSwm9
Recently, @WellinksHealth announced a study w/ the @COPDFoundation. It aims to determine whether Wellinks can improve outcomes for patients w/ COPD by measuring the impact on health-related quality of life & health care resource utilization. Learn more ⬇️ https://t.co/QD38nFcKqu
Excited to announce Akili plans to go public through combination with Social Capital Suvretta Holdings Corp. I. This important step advances our work to reimagine medicine and will help us to better serve patients living with cognitive impairments $DNAA
https://t.co/OZFLrFOZIP